Reversal of multidrug resistance in KB cells with tea polyphenol antioxidant capacity

Cancer Biology and Therapy

Volumn 4, Issue 4, 2005, Pages 474-479

  Mei, Yuying ^a   Wei, Dongzhi ^b   Liu, Jianwen ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

( ) epigallocatechin gallate; Doxorubicin; Multidrug resistance; Reactive oxygen species; Tea polyphenols

Indexed keywords

DOXORUBICIN; EPIGALLOCATECHIN GALLATE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; TEA POLYPHENOL; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRAIN KB; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; OXIDATIVE STRESS; TEA;

EID: 25144506564     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.4.1698     Document Type: Article

References (22)

1. Ng IO, Liu CL, Fan ST, Ng M. Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am J Clin Pathol 2000; 113:355-63.
2. Sarkadi B, Muller M. Search for specific inhibitors of multidrug resistance in cancer. Semin Cancer Biol 1997; 8:171-82.
3. Stein U, Walther W, Laurencot CM, Scheffer GL, Scheper RJ, Shoemaker RH. Tumor necrosis factor-alpha and expression of the multidrug resistance- associated genes LRP and MRP. J Natl Cancer Inst 1997; 89:807-13.
4. Deshpande SS, Angkeow P, Huang J, Ozaki M, Irani K. Rac1 inhibits TNF-alpha-induced endothelial cell apoptosis: dual regulation by reactive oxygen species. FASEB J 2000; 14:1705-14.
5. Yamane Y, Furuichi M, Song R, Van NT, Mulcahy RT, Ishikawa T, Kuo MT. Expression of multidrug resistance protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol Chem 1998; 273:31075-85.
6. Ziemann C, Burkle A, Kahl GF, Hirsch-Ernst KI. Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures. Carcinogenesis 1999; 20:407-14.
7. Huang MT, Ho CT, Wang ZY, Ferraro T, Finnegan-Olive T, Lou YR, Mitchell JM, Laskin JD, Newmark H, Yang CS, et al. Inhibitory effects of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 1992; 13:947-54.
8. Katiyar SK, Mukhtar H. Tea in chemoprevention of cancer, epidemiologic and experimental studies. Int J Oncol 1996; 8:221-38.
9. Narasiwa T, Fukaura Y. A very low dose of green tea polyphenols in drinking water prevents N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res 1993; 84:1007-9.
10. Yasuyuki S, Tomomoi S, Takashi S. Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance. Toxicology Lett 2000; 114:155-62.
11. Gerd S, Manfred V. Green tea catechins (EGCG and EGC) have modulating effecs on the activity of doxorubicin in drug-resistance cell lines. Anticancer drugs 1997; 8:265-8.
12. Sugiyama K, Ueda H. Protective effects of tea on toxic side platinum effects by anticancer drug, cisplatin in mice. Proceeding of the International Symposium on Tea Science 1991; 352:26-9.
13. Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst 1993; 85:1038-49.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
15. Sejda P, Parce JW, Seeds MS, Bass DA. Flow cytometric quantitation of oxidative produce formation by polymorphonuclear leukocytes during phagocytosis. J Immunol 1984; 133:3303-7.
16. Rajesh K, Lawrence DM. Multidrug resistance (MDR) in cancer mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 2000; 11:265-83.
17. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res 1994; 54:1969S-75S.
18. Hao XY, Widersten M, Ridderstorm M, Hellamn U, Mamervik B. Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: Establishment of class Mu glutasthione transferase M3-3 as the domination isoenzyme. Biochem J 1994; 297:59-67.
19. Kim R, Hirabayashi N, Nishiyama M, Jinushi K, Toge T, Okada K. Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice. Int J Cancer 1992; 50:760-6.
20. Kamath N, Grabowski D, Ford J, Kerrigan D, Pommier Y, Ganapathi R. Overexpression of P-glycoprotein and alterations in topoisomerase II in p388 mouse leukaemia cells selected in vivo for resistance to motoxantrone. Biochem Pharmacol 1992; 44:937-45.
21. Borst P, Kool PM, Evers R. Do cMOAT (MRP2), other MRP homologues and LRP play a role in MDR. Cancer Biol 1997; 8:205-13.
22. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG. Overexpression of multidrug resistance-associated protein increases resistance to natural product drugs. Cancer Res 1994; 54:357-61.